Efficacy and safety of setmelanotide, a melanocortin-4 receptor agonist, in patients with Bardet-Biedl syndrome and Alström syndrome: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial with an open-label period
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Efficacy and safety of setmelanotide, a melanocortin-4 receptor agonist, in patients with Bardet-Biedl syndrome and Alström syndrome: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial with an open-label period
Authors
Keywords
-
Journal
Lancet Diabetes & Endocrinology
Volume 10, Issue 12, Pages 859-868
Publisher
Elsevier BV
Online
2022-11-08
DOI
10.1016/s2213-8587(22)00277-7
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Monogenic obesity syndromes provide insights into the hypothalamic regulation of appetite and associated behaviors
- (2022) I. Sadaf Farooqi BIOLOGICAL PSYCHIATRY
- Bardet-Biedl syndrome proteins regulate intracellular signaling and neuronal function in patient-specific iPSC-derived neurons
- (2021) Liheng Wang et al. JOURNAL OF CLINICAL INVESTIGATION
- The morbid genome of ciliopathies: an update
- (2020) Hanan E. Shamseldin et al. GENETICS IN MEDICINE
- Effect of setmelanotide, a melanocortin‐4 receptor agonist, on obesity in Bardet‐Biedl syndrome
- (2020) Robert Haws et al. DIABETES OBESITY & METABOLISM
- Bardet‐Biedl syndrome: Weight patterns and genetics in a rare obesity syndrome
- (2020) Jeremy Pomeroy et al. Pediatric Obesity
- Efficacy and safety of setmelanotide, an MC4R agonist, in individuals with severe obesity due to LEPR or POMC deficiency: single-arm, open-label, multicentre, phase 3 trials
- (2020) Karine Clément et al. Lancet Diabetes & Endocrinology
- The BBSome in POMC and AgRP Neurons is Necessary for Body Weight Regulation and Sorting of Metabolic Receptors
- (2019) Deng-Fu Guo et al. DIABETES
- Clinical, molecular genetics and therapeutic aspects of syndromic obesity
- (2018) E. Geets et al. CLINICAL GENETICS
- MC4R agonism promotes durable weight loss in patients with leptin receptor deficiency
- (2018) Karine Clément et al. NATURE MEDICINE
- Managing Bardet–Biedl Syndrome—Now and in the Future
- (2018) Elizabeth Forsythe et al. Frontiers in Pediatrics
- Screening for Obesity in Children and Adolescents
- (2017) et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Copy-Number Variation Contributes to the Mutational Load of Bardet-Biedl Syndrome
- (2016) Anna Lindstrand et al. AMERICAN JOURNAL OF HUMAN GENETICS
- Hyperphagia: Current concepts and future directions proceedings of the 2nd international conference on hyperphagia
- (2014) Steven B. Heymsfield et al. Obesity
- Clinical Trials in Rare Disease
- (2013) Erika F. Augustine et al. JOURNAL OF CHILD NEUROLOGY
- Bardet–Biedl syndrome
- (2012) Elizabeth Forsythe et al. EUROPEAN JOURNAL OF HUMAN GENETICS
- Patients with Bardet-Biedl Syndrome Have Hyperleptinemia Suggestive of Leptin Resistance
- (2011) Penelope P. Feuillan et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Alström syndrome: insights into the pathogenesis of metabolic disorders
- (2010) Dorothée Girard et al. Nature Reviews Endocrinology
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started